Search

everythinglearnresearchcommunity

for

Search:↓

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

Tiny needles with valproic acid can effectively regrow hair.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

The rise in tinea capitis cases in Stockholm is linked to increased African immigration.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Mice lacking Insig proteins had hair growth problems due to cholesterol buildup, but this was fixed by the drug simvastatin.

Loose anagen hair syndrome, often affecting young girls, can be diagnosed with a hair-pull test and usually gets better on its own, but severe cases may need treatment.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.

Type I interferons play a key role in the development of various skin diseases.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

A 2-year-old boy with a rare brain malformation may have Gomez–López-Hernández syndrome.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.